Investigative Site Number: 1008 — Murfreesboro, Tennessee

Investigative Site Number: 1008 is a clinical research site located in Murfreesboro, Tennessee, United States 37130-2450.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site Number: 1008 has participated in 1 clinical trials.

Therapeutic areas: Eczema, Atopic Dermatitis.

Sponsors: Kymab Limited.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site Number: 1008?

Investigative Site Number: 1008 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site Number: 1008 conducted?

Investigative Site Number: 1008 has 1 clinical trials on record. Their work covers Eczema, Atopic Dermatitis.

Is Investigative Site Number: 1008 accredited by Crixeo Health?

Investigative Site Number: 1008 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site Number: 1008?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.